Coronary Artery Bypass Graft Surgery Market Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts Report To 2016 Summary GlobalData's Medical Devices sector report, "Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Browse the full “Coronary Artery Bypass Graft Surgery Market� report at: http://www.radiantinsights.com/research/coronary-artery-bypass-graft-surgery-medicaldevices-pipeline-assessment-2016 Scope - Extensive coverage of the Coronary Artery Bypass Graft Surgery under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons to Buy The report enables you to - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date. Table Of Content: Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 6 2 Introduction 7 2.1 Coronary Artery Bypass Graft Surgery Overview 7 3 Products under Development 8 3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 8 3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 9 3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 10 3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 11 3.5 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 12 3.6 Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 13 Request Free Sample Of This Study @ http://www.radiantinsights.com/research/coronaryartery-bypass-graft-surgery-medical-devices-pipeline-assessment-2016#tabs-4 4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies 14 4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development 14 4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 16 5 Coronary Artery Bypass Graft Surgery Companies and Product Overview 17 5.1 AdvanSource Biomaterials Corporation Company Overview 17 5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 17 5.2 Axcelon Biopolymers Corp. Company Overview 20 5.2.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 20 5.3 CardioPolymers, Inc. Company Overview 21 5.3.1 CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21 5.4 CellProthera Company Overview 22 5.4.1 CellProthera Pipeline Products & Ongoing Clinical Trials Overview 22 5.5 Coromedic Ltd. Company Overview 24
5.5.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24 5.6 Cytograft Tissue Engineering, Inc. Company Overview 26 5.6.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26 5.7 Elana bv Company Overview 28 5.7.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 28 5.8 Endogene Ltd Company Overview 29 5.8.1 Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 29 5.9 Graft-Loc Inc. Company Overview 31 5.9.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 5.10 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 32 5.10.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 5.11 iiTech BV Company Overview 34 5.11.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 34 5.12 Magenta Medical Inc Company Overview 37 5.12.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 37 5.13 Miracor Medical Systems GmbH Company Overview 38 5.13.1 Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 38 Read More Reports on Medical Devices Markets: http://www.radiantinsights.com/catalog/medical-devices 5.14 Neograft Technologies, Inc. Company Overview 40 5.14.1 Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40 5.15 NuVascular Technologies Inc Company Overview 44 5.15.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44 5.16 Prekubator TTO Company Overview 45 5.16.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 45 5.17 Revivicor, Inc. Company Overview 46 5.17.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46 5.18 SeamVad Ltd. Company Overview 47 5.18.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47 5.19 St. Jude Medical, Inc. Company Overview 48 5.19.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48 5.20 Tengion, Inc. Company Overview 50 5.20.1 Tengion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50 5.21 The University of Utah Company Overview 51 5.21.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 51 5.22 Tissue Regeneration Technologies, LLC Company Overview 52 5.22.1 Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 52 5.23 University College London Company Overview 54 5.23.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 54
5.24 University of Arizona Company Overview 55 5.24.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 55 5.25 University of California, Los Angeles Company Overview 57 6 Coronary Artery Bypass Graft Surgery- Recent Developments 58 6.1 Jan 04, 2016: Cellular Regenerative Therapy Greeted by French Minister of Health 58 6.2 Dec 15, 2015: Cardiac Dimensions Announces Appointment Of Gregory D. Casciaro As President And Chief Executive Officer 58 6.3 Aug 27, 2015: Bioheart to Change Name to U.S. Stem Cell, Inc. 59 6.4 Aug 06, 2015: Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results 59 To Get More Details @ http://www.radiantinsights.com/research/coronary-artery-bypassgraft-surgery-medical-devices-pipeline-assessment-2016 6.5 May 20, 2015: Primary Lesion Treatment Using Diamondback 360 Orbital Atherectomy System Enhances Paclitaxel Deposition in Calcified Peripheral Arteries: Preclinical Data Presented at EuroPCR 2015 61 6.6 May 19, 2015: Cardiovascular Systems Peripheral and Coronary Data Featured at EuroPCR 2015 62 7 Appendix 65 7.1 Methodology 65 7.2 About GlobalData 67 7.3 Contact Us 68 7.4 Disclaimer 68 About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com